Results 161 to 170 of about 127,439 (309)

HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal, Emily Moon, Georgios Kallikas   +2 more
wiley   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

The oral vaccine intrOv is attenuated in infecting the lower airway and inducing chronic pathology. [PDF]

Infect Immun
Liu Z, Li C, Mahan S, Ren J, Hou S, Zhong G.   +5 more
europepmc   +1 more source

Development of a plant-based oral vaccine candidate against the bovine respiratory pathogen Mannheimia haemolytica. [PDF]

Front Plant Sci, 2023
Kaldis A, Uddin MS, Guluarte JO, Martin C, Alexander TW, Menassa R.   +5 more
europepmc   +1 more source

Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study

The Laryngoscope, EarlyView.
COVID‐19 is associated with an increased incidence of new‐onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ...
Cali Loblundo, Warren B. Chun, Shaun A. Nguyen, Kirsten Meenan, Ashli K. O'Rourke   +4 more
wiley   +1 more source

Antigen-Containing Silk Nanoparticles: A New Potential as Oral Vaccine Carriers. [PDF]

Int J Nanomedicine
Sato M, Sakuma C, Sezutsu H, Kojima K.
europepmc   +1 more source

Efficacy of White Spot Syndrome Virus Protein VP28-Expressing Chlorella vulgaris as an Oral Vaccine for Shrimp. [PDF]

Viruses, 2023
Kim MJ, Kim SH, Kim JO, Lee TK, Jang IK, Choi TJ.   +5 more
europepmc   +1 more source

Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study

In the context of polio eradication, novel oral polio vaccines for type 2 (nOPV2) were developed, and types 1 and 3 polioviruses are being developed.
Lourdes Peña Mendez, Luis Rivera Mejía, Ananda Sankar Bandyopadhyay, Ricardo W. Rüttimann, Chris Gast   +4 more
core   +1 more source

Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti‐Tumor Drug Delivery

Macromolecular Rapid Communications, EarlyView.
Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley   +1 more source

Liposomal hydrogel-based oral vaccine delivery for targeted induction of intestinal mucosal immunity. [PDF]

Mater Today Bio
Li Z, Fan B, Ouyang C, Hu M, Song X, Chen G, Lou Y, Yang H, Sun D, Li B, Ren L.   +10 more
europepmc   +1 more source